Final CPH model on mortality with any NTM diagnosis as the main independent variable
| Final model | |||
| aHR | 95% CI | P value | |
| Any NTM diagnosis | 1.83 | 1.76 to 1.91 | <0.0001 |
| No NTM diagnosis | 1.00 | <0.0001 | |
| Demographics | |||
| Age (1-year increase) | 1.03 | 1.03 to 1.03 | <0.0001 |
| Race, n (%) | |||
| Black | 1.13 | 1.12 to 1.14 | <0.0001 |
| Other | 1.51 | 1.50 to 1.53 | <0.0001 |
| White | 1.00 | <0.0001 | |
| Sex, n (%) | |||
| Female | 0.99 | 0.98 to 0.99 | <0.0001 |
| Male | 1.00 | <0.0001 | |
| Ethnicity, n (%) | |||
| Hispanic | 0.69 | 0.69 to 0.70 | <0.0001 |
| Non-Hispanic | 1.00 | <0.0001 | |
| First dialysis modality, n (%) | |||
| Hemodialysis | 1.30 | 1.21 to 1.40 | <0.0001 |
| Peritoneal | 1.00 | <0.0001 | |
| Access type, n (%) | |||
| Catheter | 1.49 | 1.48 to 1.50 | <0.0001 |
| Graft | 1.19 | 1.17 to 1.20 | <0.0001 |
| AV fistula | 1.00 | <0.0001 | |
| Clinical risk factors | |||
| Kidney transplant | 0.15 | 0.15 to 0.16 | <0.0001 |
| HIV | 1.11 | 1.08 to 1.13 | <0.0001 |
| Chronic lung disease | 1.03 | 1.03 to 1.04 | <0.0001 |
| Cancer | 0.99 | 0.98 to 0.99 | <0.0001 |
| Diabetes | 0.92 | 0.92 to 0.93 | <0.0001 |
| Rheumatologic disease | 0.70 | 0.69 to 0.70 | <0.0001 |
| Any transplant | 0.92 | 0.91 to 0.93 | <0.0001 |
| Liver disease | 1.19 | 1.18 to 1.20 | <0.0001 |
| Cardiovascular disease | 1.02 | 1.01 to 1.03 | <0.0001 |
aHR, adjusted HR; CPH, Cox proportional hazards; NTM, non-tuberculous mycobacteria.